InsidersTradesSigma
Follow the Cipla Limited share price and the full directors' dealings record of the company, a listed equity based in India. Shares are listed on the IN market, under the authority of SEBI (PIT + SAST). Operating in the Health Care sector, Cipla Limited has logged 35 reports. Market capitalisation: €1,184.6bn. The latest transaction was reported on 30 September 2025 (Sale). Among the most active insiders: Vidya Prabhakar Rote jointly with Kiran Rote. All data is accessible without an account.
35
Insider Decl.
n/a
Thresholds
€143,568
28 ops.
Buy Volume
€110,623
4 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Cipla Limited Buy (bullish), based on 37 analysts. Average price target: ₹1,512.86.
10Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 9,567 of 29,063 companies
60.1
score / 100
Value41
Quality79
FCF yld0.7%
Earn yld3.3%
EV/EBITDA18.7x
ROE12%
Gross mgn62%
Net mgn14%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 30 September 2025
Declarations35 total
15,419 sharesEquity SharesSEBI:14b5c33db1512b0a4dbe7688b50f71b5b0c8a8b8
15,419 sharesEquity SharesSEBI:ff36a81bf8b9c48db902d6444484a759e50719ed
2,000 shares@ ₹1,590.831539.6% of flowEquity SharesSEBI:ee8bbc39ad6545f1a2b84ec900cc9fe279689b62
3,000 shares@ ₹1,587.9560.4% of flowEquity SharesSEBI:8293ff68eacf67538d846f32913fa113ae6fefc4
150 shares@ ₹1,269.80100.0% of flowEquity SharesSEBI:89f4543eab6d4f192bb7c07e0f70b000e3b76e7d
500 shares@ ₹1,273.2872.3% of flowEquity SharesSEBI:239da8f55f46c855fdc45568052e3678ea860c4c
200 shares@ ₹1,186.67527.7% of flowEquity SharesSEBI:2ede1d656435c8581a87e9a7334d27b8a0f304c4
1,000 shares@ ₹1,110.3833.7% of flowEquity SharesSEBI:af660fb1d3f80468b697de3c3930d2274f247f4d
1,000 shares@ ₹1,075.9032.4% of flowEquity SharesSEBI:ec2a3e66700da2ad33a180a9c3c2a75a23f75e8e
1,000 shares@ ₹1,119.1533.9% of flowEquity SharesSEBI:e9c13479b4e5a97c3ab81fc4205478e1cca1d6e8
10,000 shares@ ₹965.9548.5% of flowEquity SharesSEBI:7961c0108849fe0af43caad5cf5fbbcaac1b6497
10,000 shares@ ₹1,021.9551.5% of flowEquity SharesSEBI:dd1abb651d894fa9f49e4785d6e3cdbd1ca618a2
2,000 shares@ ₹1,042.0605100.0% of flowEquity SharesSEBI:d0e58482052184f9ef11a0637d816c52884a4bb9
1,215 shares@ ₹2.000.0000% mcap100.0% of flowEquity SharesSEBI:dd1ae8e899d94c0b9d88489fb71d77ecabd768fa
2,663 shares@ ₹2.000.0000% mcap100.0% of flowEquity SharesSEBI:1526cd62556d3ac1db343d2ba3d0ea47d05534c4
1,889 shares@ ₹2.000.0000% mcap100.0% of flowEquity SharesSEBI:b85f4c3bec954bec9dee67ed34b8983e8270f3c1
1,598 shares@ ₹2.000.0000% mcap100.0% of flowEquity SharesSEBI:310ff75f7021c53083ea3991c79c2b78715db640
23,960 shares@ ₹2.000.0000% mcap100.0% of flowEquity SharesSEBI:d08f8777b4e9326bf699f7d9823a70be200f291d
2,332 shares@ ₹2.000.0000% mcap100.0% of flowEquity SharesSEBI:ecdd16fe727ff9e7d1256ccd219165367f8928f1
1,833 shares@ ₹2.000.0000% mcap100.0% of flowEquity SharesSEBI:d192385f329aa6683d233a28828b810cf5a56c92
2,663 shares@ ₹2.000.0000% mcap100.0% of flowEquity SharesSEBI:bc99077521915b4ea2642aea1acb1fd809790ba8
1,775 shares@ ₹2.000.0000% mcap100.0% of flowEquity SharesSEBI:041703037f1eedfc7b54e21e4bfb978fc730fac3
1,065 shares@ ₹2.000.0000% mcap100.0% of flowEquity SharesSEBI:ab9482fa2838ed32651b7dce1150486b6332cc05
51,169 shares@ ₹2.000.0000% mcap100.0% of flowEquity SharesSEBI:d004047ef784c2bb14c2e26db7456af9b5a0ecab
25 of 35 declarations
关于 Cipla Limited
Cipla Limited 是一家印度制药公司，专门生产仿制药和医疗保健产品。该公司在孟买证券交易所上市，股票代码为 XBOM。